Industrifonden invests in Athera Biotechnologies
Industrifonden invests 11 million SEK in Swedish Life Science company Athera Biotechnologies AB. Athera Biotechnologies AB is a privately held biopharmaceutical company focused on developing a new antibody against cardiovascular diseases.Industrifonden participates in the 24 million SEK financing round led by Industrifonden, Östersjöstiftelsen and Linc Invest. The proceeds will be used to finance further clinical development of Athera’s lead project PC-mAb, currently in clinical Phase I studies, to become a Phase 2-ready project. PC-mAb provides an opportunity to address the need for